Hypertension Clinical Trials

Showing 321-340 of 3,518 trials

Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD)

NCT06384534

The investigators aim to study the effect of SOT in Swiss residents with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

Pulmonary Vascular DisorderChronic Thromboembolic Pulmonary HypertensionPulmonary Arterial Hypertension

University of Zurich40 participantsStarted Apr 2024

Zurich, Canton of Zurich, Switzerland

Not Yet RecruitingPhase 4

Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

NCT07247162

Osilodrostat has proven to be a safe and efficacious treatment for patients with CS. Demonstrating normalisation of hypercortisolaemia and in patients with hypertension and/or dysglycaemia clinically relevant and statistically significant reductions in blood pressure and glycaemia. This study aims at providing additional evidence on the safety, efficacy and appropriate dosing of osilodrostat in patients with CS, who have hypertension.

HypertensionHypercortisolemiaCushing Syndrome

RECORDATI GROUP63 participantsStarted Aug 2026

COMPLETEDNA

Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity

NCT06418074

This is a randomized, placebo-controlled, double-blinded crossover design. Nineteen patients with essential hypertension will be randomized to receive either ketone bodies (KE4) or placebo delivered by KetoneAid. After a period of 5-days treatment, effect variables will be measured (experiment day 1). After a washout period of 14 days, the subjects are crossed over to a similar treatment period with the other treatment. The study is terminated by measuring effect variables after the second treatment period (experiment day 2).

KetosisEssential Hypertension

Gødstrup Hospital20 participantsStarted Sep 2024

Herning, Denmark

Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD)

Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity

Related Searches

Songling Xuemaikang Capsules for Cerebral Small Vessel Disease

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods

Sleep Hygiene Education and Blood Pressure Control in Essential Hypertension in Primary Care

Study to Investigate the Potential Health Benefits of Grapes Seeds Extract Supplementation in the Management of Elevated Blood Pressure or Stage 1 Hypertension

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)

Oura Blood Pressure Profile Study

SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)

Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

Gamification and Medication Adherence (GAME Adherence)

Impact of Canadian Haskap Berry Powder on Hypertension and Acuity in Women's Health

The Workplace-Based Hypertension Management Program

A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension